Skip to main content

Join FDA and DiMe during a 2-day virtual event.

Advancing digital health applications: priorities for innovation in real-world evidence (RWE) generation


March 08, 2022

Discussion Topic

To accelerate innovation in evidence generation to support broad acceptance of digital health applications, DiMe and the health innovation hub (hih) of the German Federal Ministry of Health is releasing a manuscript end of February to define global priorities in evidence generation related to digital health applications that will speed the use of high-quality digital medicine products in routine care. Over the last year, an international group of researchers and experts in the use of real-world data and real-world evidence generation for digital medicine products joined a set of roundtable discussions and identified innovative approaches to digital medical product evaluation.

Join the co-authors of this manuscript in an open discussion and learn about the methodological challenges and opportunities for this emerging field of research, alongside examples of novel approaches to health evaluation research that can be readily applied to the evaluation of DiGA in Germany and novel digital health applications more broadly globally.

Watch the recording

View the hih DiMe Journal Club Slides

Read the publication

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today